Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

IyTroLine

ABSTRACT: Tromatobia lineatoria, genomic and transcriptomic data

PROVIDER: PRJEB59789 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR10879932.fastq.gz	Fastqsanger.gz
	ERR10890735_1.fastq.gz	Fastqsanger.gz
	ERR10890735_2.fastq.gz	Fastqsanger.gz
	ERR11837466_1.fastq.gz	Fastqsanger.gz
	ERR11837466_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

iyTroLine

Project description:Tromatobia lineatoria

| PRJEB59790 | ENA

Tromatobia lineatoria

Project description:Tromatobia lineatoria overview

| PRJNA946006 | ENA

iyTroLine1

Project description:Tromatobia lineatoria genome assembly, iyTroLine1

| PRJEB60676 | ENA

iyTroLine1 alternate haplotype

Project description:Tromatobia lineatoria genome assembly, iyTroLine1, alternate haplotype

| PRJEB60675 | ENA

iyTroLine1.Wolbachia_sp_1

Project description:Wolbachia endosymbiont (group A) of Tromatobia lineatoria genome assembly, iyTroLine1.Wolbachia_sp_1

| PRJEB74881 | ENA

Tropheryma whipplei proteome - Analyses of new genomic, transcriptomic or proteomic data commonly result in trashing many unidentified data escaping the ‘canonical’ DNA-RNA-protein scheme

Project description:Analyses of new genomic, transcriptomic or proteomic data commonly result in trashing many unidentified data escaping the ‘canonical’ DNA-RNA-protein scheme. Testing systematic exchanges of nucleotides over long stretches produces inversed RNA pieces (here named “swinger” RNA) differing from their template DNA. These may explain some trashed data. Here analyses of genomic, transcriptomic and proteomic data of the pathogenic Tropheryma whipplei according to canonical genomic, transcriptomic and translational 'rules' resulted in trashing 58.9% of DNA, 37.7% RNA and about 85% of mass spectra (corresponding to peptides). In the trash, we found numerous DNA/RNA fragments compatible with “swinger” polymerization. Genomic sequences covered by «swinger» DNA and RNA are 3X more frequent than expected by chance and explained 12.4 and 20.8% of the rejected DNA and RNA sequences, respectively. As for peptides, several match with “swinger” RNAs, including some chimera, translated from both regular, and «swinger» transcripts, notably for ribosomal RNAs. Congruence of DNA, RNA and peptides resulting from the same swinging process suggest that systematic nucleotide exchanges increase coding potential, and may add to evolutionary diversification of bacterial populations.

2017-12-18 | PXD006238 | Pride

tfGorAlbo

Project description:Gordius_albopunctatus, genomic and transcriptomic data

| PRJEB78907 | ENA

Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer

Project description:NO-CUT is a one-stage phase II trial seeking to establish whether an oxaliplatin-based chemotherapy preceding standard neo-adjuvant fluoropyrimidines-based chemo radiotherapy, can safely spare demolitive surgical intervention in patients with operable rectal cancer, without increasing the risk of distant relapse. The trial also has a translational component aimed at establishing whether selected genomic, epigenetic, and transcriptomic markers are predictive of tumor and patient outcome.

| 2275988 | ecrin-mdr-crc

Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma

Project description:The purpose of this study is the investigation of new host-microbiome interactions promoting adenoma formation and adenocarcinoma progression. For that purpose, the investigators will collect saliva, stool and colon biopsy specimens from patients referred to colonoscopy or surgical resection of colorectal tumor. Besides, a questionnaire about diet, lifestyle and medical history will be collected. Sample analysis will involve simultaneous characterization of host and microbiota genomic and transcriptomic components.

| 2228596 | ecrin-mdr-crc

ilTheFirm

Project description:Thera firmata, genomic and transcriptomic data

| PRJEB74678 | ENA